|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.04 USD | -3.40% |
|
+2.65% | -3.29% |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
| 06-09 | Zai Lab Says China Approves Tivdak for Cervical Cancer Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.98B | - | ||||
| 62.21B | |||||
| 59.45B | |||||
| 38.9B | |||||
| 36.4B | - | ||||
| 29.52B |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
